Vitamin pills increase mortality

Denmark - Vitamins A, E and beta carotene, taken singly or with other supplements, 'significantly increase mortality' according to a review study released by the Cochrane Hepato-Biliary Group* at Copenhagen University Hospital. Their study, published in the Journal of the American Medical Association (JAMA), did not find evidence that vitamin C could increase longevity, but did find that selenium tended to reduce the risk of death.

The Copenhagen researchers analysed 68 previous trials of the five antioxidant supplements, involving 232,606 participants, and say their findings contradict those of observational studies that claim antioxidants improve health. ‘Considering that 10-20% of the adult population (80-160 million people) in North America and Europe may consume the assessed supplements, the public health consequences may be substantial.’

The team reported that 47 ‘low-bias risk’ trials, with 180,938 participants, were ‘best quality’. Based on those low-bias studies, vitamin supplements were found to be associated with a 5% increased risk of mortality. Beta carotene was associated with a 7% risk, vitamin A with a 16% risk and vitamin E with a 4% risk. No increased mortality risk with vitamin C or selenium were seen.

* The Cochrane is an international network of experts who carry out systematic reviews of scientific evidence on health interventions.

08.03.2007

More on the subject:

Related articles

Photo

News • Skin-like optical phantom

Improving medical device testing for all skin colors

Researchers have developed realistic skin-mimicking models that could help improve the accuracy of optical medical devices and wearable sensors across a wider range of skin tones.

Photo

News • Study explores conformational plasticity

Shape-shifting: the key to norovirus infectiousness?

The human norovirus is the leading cause of acute gastroenteritis worldwide, infecting 600–700 million people each year. A new study could help explain the high infectivity of the virus.

Photo

News • Anti-inflammatory treatment

New therapy may reduce HF risk after heart attack

After a heart attack, a new type of treatment, administered directly into the damaged blood vessel, stimulates healing. This could help prevent heart failure due to scarring, the researchers say.

Subscribe to Newsletter